Literature DB >> 15486455

Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: Synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine.

Ulrika Westerlind1, Jacob Westman, Elisabeth Törnquist, C I Edvard Smith, Stefan Oscarson, Martina Lahmann, Thomas Norberg.   

Abstract

In order to develop the non-viral Bioplex vector system for targeted delivery of genes to hepatocytes, we have evaluated the structure-function relationship for a number of synthetic ligands designed for specific interaction with the hepatic lectin ASGPr. Biotinylated ligand derivatives containing two, three or six beta-linked N-acetylgalactosamine (GalNAc) residues were synthesized, bound to fluorescent-labeled streptavidin and tested for binding and uptake to HepG2 cells using flow cytometry analysis (FACS). Uptake efficiency increased with number of displayed GalNAc units per ligand, in a receptor dependent manner. Thus, a derivative displaying six GalNAc units showed the highest uptake efficacy both in terms of number of internalizing cells and increased amount of material taken up per each cell. However, this higher efficiency was shown to be due not so much to higher number of sugar units, but to higher accessibility of the sugar units for interaction with the receptor (longer spacer). Improving the flexibility and accessibility of a trimeric GalNAc ligand through use of a longer spacer markedly influenced the uptake efficiency, while increasing the number of GalNAc units per ligand above three only provided a minor contribution to the overall affinity. We hereby report the details of the chemical synthesis of the ligands and the structure-function studies in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486455     DOI: 10.1023/B:GLYC.0000045095.86867.c0

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  30 in total

1.  Synthesis of antisense oligonucleotides conjugated to a multivalent carbohydrate cluster for cellular targeting.

Authors:  Martin A Maier; Constantin G Yannopoulos; Nazim Mohamed; Arlene Roland; Hans Fritz; V Mohan; George Just; Muthiah Manoharan
Journal:  Bioconjug Chem       Date:  2003 Jan-Feb       Impact factor: 4.774

2.  Molecular characterization of the rat Kupffer cell glycoprotein receptor.

Authors:  Andrew J Fadden; Oliver J Holt; Kurt Drickamer
Journal:  Glycobiology       Date:  2003-04-02       Impact factor: 4.313

3.  In vivo nuclear delivery of oligonucleotides via hybridizing bifunctional peptides.

Authors:  L J Brandén; B Christensson; C I Smith
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

4.  Defined geometry of binding between triantennary glycopeptide and the asialoglycoprotein receptor of rat heptocytes.

Authors:  K G Rice; O A Weisz; T Barthel; R T Lee; Y C Lee
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

Review 5.  Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications.

Authors:  Jian Wu; Michael H Nantz; Mark A Zern
Journal:  Front Biosci       Date:  2002-03-01

6.  Binding modes of mammalian hepatic Gal/GalNAc receptors.

Authors:  Y C Lee
Journal:  Ciba Found Symp       Date:  1989

7.  Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.

Authors:  J S Remy; A Kichler; V Mordvinov; F Schuber; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes.

Authors:  Moganavelli Singh; Mario Ariatti
Journal:  J Control Release       Date:  2003-10-30       Impact factor: 9.776

9.  Cholesterol derivative of a new triantennary cluster galactoside directs low- and high-density lipoproteins to the parenchymal liver cell.

Authors:  E A Biessen; H Vietsch; T J Van Berkel
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

10.  A targeted peptide nucleic acid to down-regulate mouse microsomal triglyceride transfer protein expression in hepatocytes.

Authors:  Sabine M W van Rossenberg; Karen M Sliedregt-Bol; Perry Prince; Theo J C van Berkel; Jacques H van Boom; Gijs A van der Marel; Erik A L Biessen
Journal:  Bioconjug Chem       Date:  2003 Nov-Dec       Impact factor: 4.774

View more
  6 in total

Review 1.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

Review 2.  Oligonucleotide Therapies: The Past and the Present.

Authors:  Karin E Lundin; Olof Gissberg; C I Edvard Smith
Journal:  Hum Gene Ther       Date:  2015-08-03       Impact factor: 5.695

3.  Synthesis and Excellent Duplex Stability of Oligonucleotides Containing 2'-Amino-LNA Functionalized with Galactose Units.

Authors:  Rajesh Kumar; Annika Ries; Jesper Wengel
Journal:  Molecules       Date:  2017-05-21       Impact factor: 4.411

Review 4.  ASGR1 and Its Enigmatic Relative, CLEC10A.

Authors:  J Kenneth Hoober
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

5.  Mega-High-Throughput Screening Platform for the Discovery of Biologically Relevant Sequence-Defined Non-Natural Polymers.

Authors:  Michal Avital-Shmilovici; Xiaohe Liu; Thomas Shaler; Andrew Lowenthal; Pauline Bourbon; Janey Snider; Arlyn Tambo-Ong; Claire Repellin; Kenya Yniguez; Lidia Sambucetti; Peter B Madrid; Nathan Collins
Journal:  ACS Cent Sci       Date:  2022-01-11       Impact factor: 14.553

6.  Ligand conjugate SAR and enhanced delivery in NHP.

Authors:  Richard James Holland; Kieu Lam; Xin Ye; Alan D Martin; Mark C Wood; Lorne Palmer; David Fraser; Kevin McClintock; Sara Majeski; Agnes Jarosz; Amy C H Lee; Emily P Thi; Adam Judge; James Heyes
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 12.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.